Centaurus Financial Inc. Has $169,000 Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

Centaurus Financial Inc. raised its stake in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) by 7.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,996 shares of the company’s stock after buying an additional 985 shares during the period. Centaurus Financial Inc. owned 0.21% of Global X Genomics & Biotechnology ETF worth $169,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Atria Investments Inc acquired a new position in shares of Global X Genomics & Biotechnology ETF during the 3rd quarter worth about $122,000. Corrado Advisors LLC grew its stake in shares of Global X Genomics & Biotechnology ETF by 3.0% in the 3rd quarter. Corrado Advisors LLC now owns 64,224 shares of the company’s stock valued at $723,000 after purchasing an additional 1,894 shares during the period. James J. Burns & Company LLC raised its stake in Global X Genomics & Biotechnology ETF by 6.0% during the third quarter. James J. Burns & Company LLC now owns 18,293 shares of the company’s stock worth $207,000 after acquiring an additional 1,038 shares in the last quarter. Sanctuary Advisors LLC bought a new position in shares of Global X Genomics & Biotechnology ETF during the second quarter valued at $590,000. Finally, One Capital Management LLC boosted its stake in shares of Global X Genomics & Biotechnology ETF by 22.1% in the 2nd quarter. One Capital Management LLC now owns 680,311 shares of the company’s stock valued at $7,102,000 after purchasing an additional 123,339 shares in the last quarter. 56.95% of the stock is currently owned by institutional investors and hedge funds.

Global X Genomics & Biotechnology ETF Stock Up 2.6 %

Shares of Global X Genomics & Biotechnology ETF stock opened at $10.83 on Thursday. Global X Genomics & Biotechnology ETF has a 12-month low of $9.52 and a 12-month high of $12.53. The stock has a market capitalization of $79.17 million, a P/E ratio of -4.61 and a beta of 1.03. The company has a 50-day simple moving average of $10.71 and a 200 day simple moving average of $10.85.

Global X Genomics & Biotechnology ETF Company Profile

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.